Dedicated to Diabetes R&D – Profil Pursues Excellence

Dedicated to Diabetes R&D – Profil Pursues Excellence

February 2013 – Profil Institute’s Dr. Marcus Hompesch discusses the company science driven, therapeutically focused approach to early phase clinical research and development.
Read the full article at Life Science Leader magazine »